Why investors search for Cohere access
Cohere has built a reported $240 million annual recurring revenue business with roughly 70 percent gross margins as of a February 2026 investor memo reviewed by CNBC, positioning itself against OpenAI, Anthropic and Google in enterprise AI. CEO Aidan Gomez has described Cohere as a potential "pure play AI investment opportunity" for public market investors, a framing that keeps pre-IPO interest active even without a filing.
The April 2026 acquisition of Germany's Aleph Alpha, backed by a $600 million commitment from Germany's Schwarz Group and a term sheet that TechCrunch reported valued the combined company near $20 billion, sharpened that interest further. The deal's sovereign AI positioning and Cohere's investor base, which CNBC's reporting on the same memo noted includes Nvidia and Salesforce Ventures, add to the profile investors track ahead of any listing.
What can block access
Cohere has not filed a registration statement for an IPO, so there is no prospectus, no public float and no exchange ticker to buy against. Private company shares are typically restricted stock, and any transfer requires company or existing-holder approval plus documentation that a retail brokerage account does not provide.
The Aleph Alpha transaction itself is not yet closed and remains subject to regulatory and shareholder approval, which adds a layer of deal risk on top of the ordinary uncertainty around private valuations. Reported figures like the $6.8 billion mark from August 2025 and the roughly $20 billion term sheet figure from April 2026 come from different transactions and are not interchangeable, current, executable prices.
How Segmara helps
Segmara tracks Cohere against dated, named-source developments, such as CEO statements to Bloomberg, investor memo figures reported by CNBC, and deal terms reported by Reuters and TechCrunch, rather than secondary-market chatter or unsourced rumor. That keeps the page anchored to what has actually been reported and when.
Cohere has no secondary-market mark on Segmara, so the site does not display an indicative price for the name. Segmara does not sell, broker, or arrange share purchases; any private transaction is subject to eligibility, availability, transfer approval, documentation, pricing and final terms.